Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression-Reference-Cited by-同舟云学术

Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression

Published:1997-01 Issue:1 Volume:99 Page:28-37
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Essayan David M.,Huang Shau-Ku,Kagey-Sobotka Anne,Lichtenstein Lawrence M.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles;Sutherland;J Biol Chem,1958

2. Multiple cyclic nucleotide phosphodiesterases;Beavo;Mol Pharmacol,1994

3. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes–their potential utility in the therapy of asthma;Nicholson;Pulm Pharmacol,1994

4. 3`,5`-cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition;Drees;Cancer Res,1993

5. A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs;Bolger;Mol Cell Biol,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19

2. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders;Autoimmunity Reviews;2023-05

3. Effect of a single sub-dose of ketamine on postoperative fatigue syndrome in colorectal cancer patients undergoing radical laparoscopic surgery: A double-blind, pilot study;Journal of Affective Disorders;2022-09

4. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022;Molecules;2022-08-04

5. Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases;International Journal of Molecular Sciences;2021-03-05